Skip to Content

Amdocs Limited

Company NameAmdocs Limited
Stock SymbolDOX

On January 23, 2019, Spruce Point Capital Management published a report alleging that Amdocs “engineered superficial top and bottom-line growth” through “opaque M&A, aggressive percentage-of-completion accounting, software cost capitalization, and repeated one-off net tax benefits.” On this news, shares of Amdocs  fell $5.41, or nearly 9%, to close at $55.06 on January 23, 2019, thereby injuring investors. 

Submit Your Information

If you suffered a loss on your Amdocs Limited investments or would like to inquire about joining an action to recover your loss under the federal securities laws, please complete the form below.

An attorney will contact you at no cost to provide you information about joining the action and answer your questions. Please note that submission of this form does not by itself form an attorney-client relationship nor does filing out this form mean you have joined any lawsuit.

Shares Purchased

Number of SharesBuy DatePrice Per ShareAdd

Shares Sold

Number of SharesSell DatePrice Per ShareAdd